Iqvia Holdings Inc (N:IQV)

Business Focus: Biotechnology & Medical Research

Jul 15, 2019 12:40 pm ET
Martin Marietta Appoints New Member to Board of Directors
Martin Marietta Materials, Inc. (NYSE:MLM) today announced the appointment of Thomas (Tom) H. Pike as an independent member to its Board of Directors, effective July 15, 2019. With Mr. Pike’s appointment, the Martin Marietta Board is comprised of...
Jul 09, 2019 12:15 pm ET
IQVIA to Announce Second-Quarter 2019 Results on July 24, 2019
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will announce its second-quarter 2019 financial results before the market opens on Wednesday, July 24, 2019. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Daylight Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at
Jun 25, 2019 04:00 am ET
IQVIA Introduces Patient Centered Endpoints Solution with Transformative eCOA Technology Platform
IQVIA™ (NYSE:IQV) today announced the launch of the Patient Centered Endpoints (PCE) solution, an innovative science and technology-enabled approach that captures quantified evidence of patients’ experiences during clinical trials and real world studies. This disruptive technology enables trial sponsors to better understand the patients’ experiences on various therapies, reduce study implementation timelines, and enhance data transparency.
Jun 17, 2019 04:00 am ET
Chiesi Group Selects IQVIA’s OCE Technology Platform to Develop a Customer Centric Ecosystem across the Organization
IQVIA™ (NYSE:IQV) today announced that Chiesi Farmaceutici, the international research-focused healthcare Group (Chiesi Group) is leveraging IQVIA Technologies’
Jun 13, 2019 12:15 pm ET
IQVIA’s OCE Technology Platform Selected by Ferring Pharmaceuticals
IQVIA™ (NYSE:IQV) today announced that Ferring Pha
Jun 04, 2019 04:00 am ET
IQVIA’s OCE Technology Platform Selected by Zambon to Establish a Global Multichannel Commercial Engagement Model for OTC Business
IQVIA™ (NYSE:IQV) today announced that Zambon, an Italian multinational pharmaceutical and fine-chemical company, has selected
May 30, 2019 12:15 pm ET
IQVIA Real World Capabilities and Expertise Support Path to Label Expansion
IQVIA™ (NYSE:IQV) is pleased to have provided support towards the approval from the U.S. Food and Drug Administration to expand the indications for IBRANCE® (palbociclib) in combination with an aromatase inhibitor or fulvestrant to include the treatment of men with hormone receptor-positive (HR+), human epidermal growth factor receptor
May 30, 2019 04:00 am ET
IQVIA™ Institute for Human Data Science Releases Global Oncology Trends 2019 Study: Record Number of Cancer Drugs Launched in 2018 across 17 Indications
The IQVIA™ Institute for Human Data Science found in its latest report, Global Oncology Trends 2019: Therapeutics, Clinical Development and Health System Implications, that in 2018 a record-setting 15 new active substance (NAS) oncology treatments with 17 indications, including one tissue-agnostic therapy, launched in the U.S. Those 2018 debuts bring the total number of new oncology therapeutics launched since 2013 to 57 covering 89 approved indications for 23 different tumor types.
May 28, 2019 04:00 am ET
IQVIA Women Leaders Recognized for Their Outstanding Contributions to the Advancement of Healthcare
IQVIA™ (NYSE:IQV) today announced that three of the company’s women leaders have received significant awards for their leadership, vision and strategic abilities to drive disruptive technologies, improve health outcomes, and advance innovation.
May 23, 2019 12:15 pm ET
IQVIA to Participate in William Blair Growth Stock Conference on June 5, 2019
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the William Blair 39th Annual Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019 at 10:40 a.m. CT / 11:40 a.m. ET.
May 14, 2019 12:15 pm ET
IQVIA to Host Financial Analyst and Investor Conference on June 18, 2019
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will host an Analyst and Investor Conference in New York City on Tuesday, June 18, 2019. Management will provide an update on the business, with presentations starting at 9:00 a.m. ET and concluding at approximately 1:00 p.m. ET. Registration is required to attend the event.
May 13, 2019 12:15 pm ET
IQVIA Launches IQVIA MedTech Dedicated to Medical Device and Diagnostics Industry
IQVIA™ (NYSE:IQV) today announced the launch of IQVIA MedTech and its dedicated industry focused solutions and services for the medical device and in vitro diagnostics market, and for companies with combination products. IQVIA MedTech empowers companies to orchestrate operations across their entire product lifecycle, from concept-to-market
May 09, 2019 04:00 am ET
IQVIA™ Institute for Human Data Science Releases 2019 Medicines Report on U.S. Drug Consumption; U.S. Rx Opioid Volume Declined 17% in 2018 – Largest Single-Year Drop Ever Recorded
The latest report from the IQVIA™ Institute for Human Data Science found prescription opioid dosage volume — as defined by morphine milligram equivalents, or MMEs — declined 17 percent in 2018, marking the single-largest annual drop ever recorded within the U.S. market.
May 07, 2019 01:17 pm ET
IQVIA Announces Pricing of Offering of Senior Notes
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,100,000,000 in aggregate principal amount of senior notes due 2027 (the “notes”). The net proceeds from the notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility, to pay fees and expenses related to the notes offering and for other general corporate purposes.
May 07, 2019 03:32 am ET
IQVIA Announces Offering of Senior Notes
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $1,100,000,000 in gross proceeds through an offering of senior notes due 2027. The net proceeds from the notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility, to pay fees and expenses related to the notes offering and for other general corporate purposes. The consummation of the notes offering is subject to market and other customary conditions.
May 01, 2019 03:00 am ET
IQVIA Reports First-Quarter 2019 Results, Reaffirms Full-Year Guidance
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2019.
Apr 25, 2019 04:00 am ET
IQVIA’s OCE Technology Platform Selected by Salehiya Medical to Enhance Customer Experience in Saudi Arabia
IQVIA™ (NYSE:IQV) today announced that Salehiya Medical, a leading Saudi Arabian healthcare distribution company, has selec
Apr 24, 2019 04:00 am ET
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp® in Support of Société Générale’s Strategic Review
United Health Products, Inc. (OTC: UEEC), (“UHP” or “the company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it had retained IQVIA Inc. to conduct a U.S....
Apr 23, 2019 04:00 am ET
IQVIA Institute for Human Data Science Study: Record 59 New U.S. Drugs Launched in 2018, Success Rates Fall, R&D Trends Could Improve Productivity by 2023
Ongoing changes in the clinical development process led to a record number of drug approvals in 2018, with 59 novel treatments reaching patients in the United States alone. During the next five years, trial productivity will be heavily influenced by key trends, including wider use of biomarkers, pre-screened patient pools, regulatory shifts and application of artificial intelligence and predictive analytics.
Apr 17, 2019 12:15 pm ET
IQVIA to Announce First-Quarter 2019 Results on May 1, 2019
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its first-quarter 2019 financial results before the market opens on Wednesday, May 1, 2019. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Daylight Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at
Apr 09, 2019 06:30 am ET
IQVIA Releases Enhanced OCE Capability
IQVIA™ (NYSE: IQV) today announced the expansion of
Mar 06, 2019 01:00 am ET
IQVIA Announces Pricing of Secondary Public Offering
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 5,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC and investment funds associated with Bain Capital Investors, LLC (the “Selling Stockholders”), at a price to the public of $141.00 per share. IQVIA intends to repurchase from the underwriters 1,000,000 shares (the “Repurchase”).
Mar 05, 2019 11:52 am ET
IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 5,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC and investment funds associated with Bain Capital Investors, LLC (the “Selling Stockholders”), of which IQVIA intends to repurchase from the underwriter 1,000,000 shares (the “Repurchase”).
Mar 05, 2019 03:00 am ET
IQVIA Launches E360 Genomics
IQVIA™ (NYSE: IQV) today announced the launch of a patented technology platform that advances real-world research and protects genomic data privacy. E360™ Genomics, a scalable, privacy-preserving genotypic-phenotypic database solution, provides an efficient way to conduct genomic research with genomic and clinical databases.
Mar 05, 2019 02:45 am ET
Market Trends Toward New Normal in Ritchie Bros. Auctioneers, Empire State Realty Trust, Synergy Resources, IQVIA, Intrexon, and Denbury Resources — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ritchie Bros. Auctioneers Incorporated (NYSE:RBA), Empire State Realty...
Mar 04, 2019 11:15 am ET
IQVIA’s FluSTAR Online Dynamic Platform Helps Consumers Track Local Rates of Flu, Allergy and Asthma
IQVIA™ (NYSE:IQV), a leader in human data science, provides consumers with quick and easy access to seasonal suffering data, giving them unique insights into important health related information. Recent data show that flu season is hitting hard in several key markets.
Feb 28, 2019 11:15 am ET
IQVIA to Present at the Barclays Global Healthcare Conference on March 12, 2019
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), announced today that Michael McDonnell, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2019 at 1:35 p.m. EDT.
Feb 21, 2019 03:00 am ET
Carol J. Burt Joins IQVIA Board of Directors
IQVIA™ (NYSE:IQV) today announced the appointment of Carol J. Burt to its board of directors, effective today. A principal of private investment firm Burt-Hilliard Investments for more than a decade, Burt is a former executive officer of WellPoint, Inc. (now Anthem, Inc.), lastly as Senior Vice President, Corporate Finance and Development, an
Feb 14, 2019 02:00 am ET
IQVIA Reports Fourth-Quarter and Full-Year 2018 Results, Issues First-Quarter and Full-Year 2019 Guidance
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter and year ended December 31, 2018.
Feb 11, 2019 03:00 am ET
IQVIA Introduces RIM Smart, the Industry’s First Fully Integrated, End-to-End Regulatory Information Management System
IQVIA™ (NYSE:IQV) today announced the launch of IQVIA RIM Smart, the first fully integrated, cloud-based, end-to-end regulatory information management solution for life sciences. Designed to leverage artificial intelligence (AI) and machine learning (ML), IQVIA Technologies’ new solution enables intellige
Feb 08, 2019 03:10 am ET
Recent Analysis Shows Amerco, McKesson, Ophthotech, IQVIA, Highwoods Properties, and ABM Industries Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Amerco (NASDAQ:UHAL), McKesson Corporation (NYSE:MCK), Ophthotech...
Feb 04, 2019 04:59 am ET
IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
IQVIA™ (NYSE:IQV) today announced the launch of IQVIA™ Biotech and its new approach to delivering tailored clinical and commercial solutions for small biotech and biopharma companies. This solutions suite, supported by more than 1,000 dedicated employees, will deliver simplified operating procedures, specialized teams, and services
Jan 31, 2019 03:00 am ET
IQVIA Launches Next Generation Site Portal Technology Capabilities to Streamline Clinical Trial Communications
IQVIA™ (NYSE:IQV) today launched two new capabilities to support clinical teams more easily and quickly share cross-trial training materials and safety notifications. These features were co-designed, tested, and are now in use by two of the top-five pharmaceutical companies.
Jan 30, 2019 01:45 am ET
IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its fourth-quarter and full-year 2018 financial results and issue 2019 guidance before the market opens on Thursday, February 14, 2019. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at
Jan 29, 2019 03:00 am ET
IQVIA Institute for Human Data Science Study: Global Medicine Spending Exceeds $1.5 Trillion by 2023 as Spending Growth Steadies
Total spending on medicines is expected to top $1.5 trillion by 2023, up 50 percent from 2014, even as annual growth moderates at 3-6 percent on an annual compound basis compared to 6.3 percent over the past five years, according to new research released from the IQVIA™ Institute for Human Data Science. The study found global drug spending reached $1.2 trillion in 2018, with the key drivers of growth during the next five years to be the United States and pharmerging markets with 4-7 percent and 5-8 percent compound annual growth respectively.
Jan 22, 2019 02:30 am ET
IQVIA Named to FORTUNE’s 2019 List of “World’s Most Admired Companies”
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has once again been named to FORTUNE magazine’s “World’s Most Admired Companies” list. IQVIA received the distinction in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks in quality of management, effectiveness in conducting business globally, wise use of corporate assets, and value as a long-term investment.
Jan 14, 2019 02:35 am ET
Report: Exploring Fundamental Drivers Behind IQVIA, The Ultimate Software Group, Brightcove, Selective Insurance Group, XPO Logistics, and Magellan Midstream Partners — New Horizons, Emerging Trends,
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IQVIA Holdings Inc. (NYSE:IQV), The Ultimate Software Group, Inc....
Jan 08, 2019 03:00 am ET
IQVIA Announces Comprehensive Multi-Tenant SaaS Safety Platform for Life Sciences Industry
IQVIA™ (NYSE:IQV) today announced its development of a Software as a Service (SaaS) safety platform that scales to address the drug safety and surveillance challenges of life sciences organizations, ranging from emerging biopharma to large pharmaceutical companies. This SaaS solution is built to allow access from multiple users, across multip
Jan 07, 2019 03:00 am ET
IQVIA’s Orchestrated Customer Engagement (OCE) Solution Adopted by More than 30 Life Sciences Companies in First Year of Launch
IQVIA™ (NYSE:IQV) today announced that more than 30 life sciences companies have selected Orchestrated Customer Engagement (OCE) as their commercial solution in the 12 months since the groundbreaking technology
Dec 06, 2018 03:00 am ET
IQVIA Named Best Contract Research Organization Full-Service Provider in 2018 Scrip Awards
IQVIA™ (NYSE:IQV) today announced that it was awarded the 2018 Scrip Award for Best Contract Research Organization — Full-Service Provider. This marks the seventh time in the last 10 years that the company has received this award.
Dec 04, 2018 07:00 am ET
Orchestra BioMed™ Appoints C. Evan Ballantyne as Chief Financial Officer
Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, announced today that it has appointed Evan Ballantyne as its Chief...
Nov 30, 2018 03:00 am ET
IQVIA Announces Pricing of Secondary Public Offering
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 6,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc. and investment funds associated with Bain Capital Investors, LLC (the “Selling Stockholders”), at a price to the public of $124.25 per share. IQVIA intends to repurchase from the underwriter 2,000,000 shares (the “Repurchase”).
Nov 29, 2018 11:47 am ET
IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 6,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc. and investment funds associated with Bain Capital Investors, LLC (the “Selling Stockholders”), of which IQVIA intends to repurchase from the underwriter 2,000,000 shares (the “Repurchase”).
Nov 29, 2018 03:00 am ET
IQVIA’s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency
IQVIA™ (NYSE:IQV) today announced that Napo Pharmaceuticals, Inc. (Napo), a wholly-owned subsidiary of Jaguar Health, Inc., has selected
Nov 27, 2018 03:00 am ET
IQVIA’s Orchestrated Customer Engagement Selected by Novo Nordisk International Operations
IQVIA™ (NYSE:IQV) today announced that Novo Nordisk, a global healthcare company with nearly a century of innovation and leadership in diabetes care, has selected IQVIA’s market-leading Orchestrated Customer Engagement platform for deployment across Novo Nordisk International Operations.
Nov 20, 2018 03:00 am ET
Adhera Therapeutics Selects IQVIA’s OCE Technology Platform to Support Commercial Excellence
IQVIA™ (NYSE:IQV) today announced that Adhera Therapeutics Inc. (OTCQB:ATRX) has selected
Nov 15, 2018 03:00 am ET
IQVIA Launches Digital ICF Author, a SaaS eConsent Tool to Transform the Informed Consent Process
IQVIA™ (NYSE:IQV) announced today the launch of Informed Consent Form (ICF) Author, a SaaS eConsent tool for use in clinical trials. The online portal allows sponsors, sites, and contract research organizations (CROs) to produce their own ICFs for delivery via eConsent or traditional paper.
Nov 06, 2018 11:15 am ET
IQVIA to Present at the Credit Suisse Annual Healthcare Conference on November 13, 2018
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), announced today that Michael McDonnell, executive vice president and chief financial officer, will speak at the Credit Suisse 27th Annual Healthcare Conference in Scottsdale, AZ on Tuesday, November 13, 2018 at 1:40 p.m. MST / 3:40 p.m. EST.
Nov 02, 2018 03:45 am ET
New Research: Key Drivers of Growth for Shutterfly, Aegion, Columbia Property Trust, Aduro Biotech, IQVIA, and Intelsat S.A — Factors of Influence, Major Initiatives and Sustained Production
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Shutterfly, Inc. (NASDAQ:SFLY), Aegion Corporation (NASDAQ:AEGN), Columbia...
Oct 22, 2018 03:00 am ET
IQVIA Reports Third-Quarter 2018 Results and Updates Full-Year 2018 Guidance
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2018. On January 1, 2018, IQVIA adopted ASC 606 “Revenue from Contracts with Customers” as required by the Financial Accounting Standards Board. Under this new standard, IQVIA recognizes revenue in the Research & Development Solutions segment on a percentage of completion basis. Additionally, ASC 606 requ
Oct 16, 2018 04:00 am ET
IQVIA’s Commercial Technology Suite for Global Deployment Selected by Roche
IQVIA (NYSE: IQV) today announced that the pharmaceuticals division of Roche (F. Hoffmann-La Roche Ltd) has selected IQVIA’s commercial technology suite for deployment across more than 100 markets. IQVIA’s Technologies suite includes the Orchestrated Customer Engagement (OCE) Sales/Marketing, Master Data Management (MDM), ePromo and Organizati
Oct 15, 2018 12:15 pm ET
IQVIA to Announce Third-Quarter 2018 Results on October 22, 2018
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its third-quarter 2018 financial results before the market opens on Monday, October 22, 2018. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at
Oct 11, 2018 03:35 am ET
Recent Analysis Shows RadNet, Electro Scientific Industries, Koppers, Momenta Pharmaceuticals, IQVIA, and Columbia Property Trust Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of RadNet, Inc. (NASDAQ:RDNT), Electro Scientific Industries, Inc....
Oct 04, 2018 04:00 am ET
IQVIA and Genomics England Launch the First Real-World Research Platform with Integrated Clinical and Genomic Data
IQVIA™ (NYSE:IQV) and Genomics England today announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access to personalized medicines.
Sep 20, 2018 04:00 am ET
IQVIA to Build Clinically-Focused Tech Solutions Suite for Life Sciences on Salesforce Health Cloud
IQVIA (NYSE: IQV) today announced the expansion of its alliance with Salesforce, the global leader in CRM and provider of Softwa
Aug 16, 2018 12:05 pm ET
Theramex Chooses IQVIA’s Orchestrated Customer Engagement
IQVIA™ (NYSE: IQV), a company dedicated to applying advanced analytics and technology in healthcare to help clients find better solutions for patients, and Theramex, an international pharmaceutical company dedicated to women’s health, today announced a global technology collaboration to integrate IQVIA’s market-leading Orchestrated Customer Engagement (OCE) platform into Theramex’s European commercial operations.
Aug 06, 2018 03:25 am ET
Detailed Research: Economic Perspectives on IQVIA, Intellia Therapeutics, Deluxe, Superior Industries International, The Navigators Group, and CAI International — What Drives Growth in Today's Competi
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of IQVIA Holdings Inc. (NYSE:IQV), Intellia Therapeutics, Inc. (NASDAQ:NTLA),...
Aug 02, 2018 12:15 pm ET
Medytox Selects IQVIA’s Enterprise Quality Management Platform, Including SmartSolve®, for Quality and Compliance Management
IQVIA™ (NYSE: IQV) today announced that the global biopharmaceutical company Medytox has selected IQVIA’s Enterprise Quality Management Solutions (EQMS) platform for quality and compliance management. The platform uniquely supports Medytox’s goals of meeting industry regulatory requirements and exceeding global quality standards.
Aug 01, 2018 04:30 am ET
IQVIA’s Jon Resnick Honored on 2018 PharmaVOICE 100 List
IQVIA (NYSE:IQV) today announced that Jon Resnick, IQVIA’s president, Real-World & Analytics Solutions, has been named to PharmaVOICE magazine’s annual list of the 100 most influential and inspiring individuals within the life sciences industry.
Jul 24, 2018 03:00 am ET
IQVIA Reports Second-Quarter 2018 Results and Raises Full-Year 2018 Revenue and Profit Guidance
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2018. On January 1, 2018, IQVIA adopted ASC 606 “Revenue from Contracts with Customers” as required by the Financial Accounting Standards Board. Under this new standard, IQVIA recognizes revenue in the Research & Development Solutions segment on a percentage of completion basis. Additionally, ASC 606 requires
Jul 10, 2018 12:15 pm ET
IQVIA to Announce Second-Quarter 2018 Results on July 24, 2018
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its second-quarter 2018 financial results before the market opens on Tuesday, July 24, 2018. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at
Jun 21, 2018 04:00 am ET
IQVIA Launches a Transformative Suite of Virtual Research Solutions
IQVIA (NYSE:IQV) announced today the launch of Virtual Research Solutions, a new suite of technology-led study options offering advances in patient-centric trial design and execution.
Jun 13, 2018 04:00 am ET
IQVIA Announces Pricing of Secondary Public Offering
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 12,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, LLC, and Dr. Dennis B. Gillings, CBE (the “Selling Stockholders”), at a price to the public of $103.50 per share. IQVIA intends to repurchase from the underwriter 4,000,000 shares (the “Repurchase”).
Jun 12, 2018 01:06 pm ET
IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 12,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, LLC, and Dr. Dennis B. Gillings, CBE (the “Selling Stockholders”), of which IQVIA intends to repurchase from the underwriter 4,000,000 shares (the “Repurchase”).
Jun 11, 2018 02:29 pm ET
IQVIA Announces Senior Secured Credit Facility Transaction to Refinance Existing Indebtedness
IQVIA Inc., a wholly-owned subsidiary of IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), today announced that it has placed approximately $1.65 billion of USD and EUR term B loans:
Jun 04, 2018 10:00 pm ET
IQVIA Launches Commercial Content Management Solution IQVIA™ ePromo
IQVIA (NYSE:IQV), a company dedicated to applying advanced analytics and technology to help healthcare clients find better solutions for patients, today announced the launch of IQVIA™ ePromo, a new cloud-based content management technology solution. ePromo makes it easier for life sciences companies to manage their regulated promotional and medic
May 24, 2018 04:00 am ET
IQVIA™ Institute for Human Data Science Study: Spending on Cancer Meds in the U.S. Doubled from 2012-2017 – Expected to Double Again by 2022 to $100 Billion
The IQVIA™ Institute for Human Data Science found in its latest report, Global Oncology Trends 2018: Innovation, Expansion and Disruption, that spending on cancer drugs in the U.S. has doubled since 2012, reaching almost $50 billion in 2017, with two-thirds of the growth tied to drugs launched within the past five years. Those drug costs are expected to double again by 2022. Outside the U.S., oncology drug costs exceeded $60 billion in 2017, driven by new product launches and increased use of existing brands.
May 17, 2018 04:28 pm ET
PruGen Pharmaceuticals Selects IQVIA’s OCE Technology Platform to Advance Field Sales and Home Office Effectiveness
IQVIA™ (NYSE:IQV), a company dedicated to applying advanced analytics and technology to help healthcare clients find better solutions for patients, today announced that
May 17, 2018 04:10 pm ET
IQVIA Reaffirms Its Second-Quarter and Full-Year 2018 Guidance, Including Adjusted EPS Growth of 13.6% to 20.4% and 14.3% to 19.9%, Respectively
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reaffirmed its second-quarter and full-year 2018 guidance previously provided on May 2nd.
May 17, 2018 03:53 pm ET
IQVIA Holdings Inc. Provides Update on Secondary Offering
IQVIA Holdings Inc. (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, announced today that in light of recent market conditions, it and the selling stockholders will not proceed with the previously announced secondary public offering and concurrent repurchase of common stock.
May 16, 2018 10:57 am ET
IQVIA Response to FDA Statement
IQVIA™ (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. We also provide a select set of services to the FDA and other government agencies. Recently, we made a correction to a kilogram conversion measurement in the United States IQVIA National
May 16, 2018 04:00 am ET
IQVIA Announces Pricing of Secondary Public Offering
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 10,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, LLC, Leonard Green & Partners, L.P., and Dr. Dennis B. Gillings, CBE and certain of his affiliates (the “Selling Stockholders”), at a price to the public of $101.85 per share. IQVIA intends to repurchase from t
May 15, 2018 12:51 pm ET
IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 10,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, LLC, Leonard Green & Partners, L.P., and Dr. Dennis B. Gillings, CBE and certain of his affiliates (the “Selling Stockholders”), of which IQVIA intends to repurchase from the underwriter 2,500,000 shares (the
May 08, 2018 12:15 pm ET
IQVIA to Present at the Bank of America Merrill Lynch Health Care Conference on May 15, 2018
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), announced today that Michael McDonnell, executive vice president and chief financial officer, will speak at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas on Tuesday, May 15, 2018 at 1:40 p.m. PDT / 4:40 p.m. EDT.
May 02, 2018 03:00 am ET
IQVIA Reports First-Quarter 2018 Results and Raises Full-Year 2018 Revenue Guidance
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2018. On January 1, 2018, IQVIA adopted ASC 606 “Revenue from Contracts with Customers” as required by the Financial Accounting Standards Board. Under this new standard, IQVIA recognizes revenue in the Research & Development Solutions segment on a percentage of completion basis. Additionally, ASC 606 requires
Apr 30, 2018 04:00 am ET
Recordati Selects IQVIA’s OCE Technology Platform and OneKey Information Services
IQVIA (NYSE:IQV), a company dedicated to applying advanced analytics and technology to help healthcare clients find better solutions for patients, and
Apr 26, 2018 04:10 am ET
Market Trends Toward New Normal in FormFactor, Corindus Vascular Robotics, Syntel, IQVIA Holdings, Hannon Armstrong Sustainable Infrastructure Capital, and Ennis — Emerging Consolidated Expectations,
NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FormFactor, Inc. (NASDAQ:FORM), Corindus Vascular Robotics,...
Apr 19, 2018 04:00 am ET
IQVIA™ Institute for Human Data Science Study: U.S. Prescription Opioid Volume Declined 12 Percent in 2017 – Largest Drop in 25 Years
The latest report from the IQVIA™ Institute for Human Data Science found prescription opioid dosage volume — as defined by Morphine Milligram Equivalents (MME) — declined 12 percent in 2017, marking the largest annual drop in more than 25 years of measurement.
Apr 18, 2018 12:15 pm ET
IQVIA to Announce First-Quarter 2018 Results on May 2, 2018
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its first-quarter 2018 financial results before the market opens on Wednesday, May 2, 2018. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at
Mar 14, 2018 11:00 pm ET
IQVIA Establishes Alliance with MuleSoft to Deliver Innovative Integration Technology to Life Sciences Companies
IQVIA (NYSE: IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced at the
Mar 13, 2018 11:00 pm ET
IQVIA Forms Alliance with Box to Provide Revolutionary, Cloud-Based Content Management Solutions to the Life Sciences and Healthcare Industries
IQVIA™ (NYSE: IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced at the eyeforpharma conference that it has entered into an alliance with
Mar 13, 2018 04:00 am ET
IQVIA Institute for Human Data Science Study: 10 Predictions for Innovation, Spending Drivers and Societal Value of Medicines that Will Transform Global Healthcare in 2018 and Beyond
According to a new report from the IQVIA™ Institute for Human Data Science, the types of medicines being developed, the way technology contributes to health, and how the value of health is calculated are all changing dramatically.
Mar 12, 2018 09:01 am ET
MDA Collaborates with IQVIA to Expand Disease Registry into the New MOVR Data Hub
CHICAGO, March 12, 2018 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association (MDA) is enhancing and expanding its disease registry into a comprehensive data hub as part of a new initiative with IQVIA (NYSE: IQV), a company known worldwide for its expertise in cutting-edge information management, analytics and technology. The new initiative will be called the MOVR (NeuroMuscular ObserVational Research) Data Hub. The enhancements will capitalize on improvements in health care information technology and systemically unify and aggregate both clinical and genetics data with patient-repor...
Feb 27, 2018 03:10 am ET
New Research: Key Drivers of Growth for Mercury General, Quintiles Transitional, Texas Roadhouse, Chanticleer, Veeco Instruments, and PotlatchDeltic — Factors of Influence, Major Initiatives and Susta
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mercury General Corporation (NYSE:MCY), Quintiles Transitional...
Feb 21, 2018 05:07 am ET
Cota Announces $40 Million Series C Financing to Advance its Cota Nodal Address™ Classification System and Real-World Evidence and Analytics Platforms
NEW YORK, Feb. 21, 2018 /PRNewswire/ -- Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE: IQV) with major participation by EW Healthcare Partners. ...
Feb 14, 2018 02:00 am ET
IQVIA Reports Fourth-Quarter and Full-Year 2017 Results, Issues First-Quarter and Full-Year 2018 Guidance
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients, today reported financial results for the quarter and full-year ended December 31, 2017. On October 3, 2016, the merger of Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc. was completed. To aid investors and analysts with year-over-year comparability for the merged business, we are
Feb 06, 2018 11:15 am ET
IQVIA to Lead Group to Expand Safety/Efficacy Monitoring of Regulated Vaccines and Biologics for the FDA Center for Biologics Evaluation and Research
IQVIA Holdings Inc. (NYSE: IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, is announcing a novel alliance with the FDA Center for Biologics Evaluation and Research (CBER) to combine advanced analytics and unparalleled information assets to monitor and assist in the evaluation of safety and effectiveness of various CBER-regulated vaccines, blood products and other biologics.
Jan 31, 2018 11:15 am ET
IQVIA to Announce Fourth-Quarter 2017 Results and Issue 2018 Guidance on February 14, 2018
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its fourth-quarter and full-year 2017 financial results and issue 2018 guidance before the market opens on Wednesday, February 14, 2018. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at
Jan 19, 2018 02:45 am ET
IQVIA Named to FORTUNE’s 2018 List of “World’s Most Admired Companies”
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has once again been named to FORTUNE magazine’s “World’s Most Admired Companies” list. IQVIA received the distinction in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks in quality of management, value as a long-term investment, effectiveness in conducting business globally and wise use of corporate assets.
Dec 20, 2017 03:10 am ET
Market Trends Toward New Normal in Ashland Global, BioCryst Pharmaceuticals, PICO, Chicago Rivet & Machine, Mercury General, and IQVIA Holdings — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Dec. 20, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ashland Global Holdings Inc. (NYSE:ASH), BioCryst...
Dec 12, 2017 11:07 am ET
IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement
IQVIA (NYSE:IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, and
Dec 12, 2017 03:00 am ET
IQVIA Launches Orchestrated Customer Engagement
IQVIA (NYSE:IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced the launch of a new commercial technology solution,
Nov 28, 2017 03:00 am ET
IQVIA Announces Pricing of Secondary Public Offering
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 10,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, LLC, and Leonard Green & Partners, L.P. (the “Selling Stockholders”). IQVIA intends to repurchase from the underwriter 2,500,000 shares (the “Repurchase”). The Repurchase will be completed outside IQVIA’s exist
Nov 27, 2017 11:39 am ET
IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 10,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, LLC, and Leonard Green & Partners, L.P. (the “Selling Stockholders”), of which IQVIA intends to repurchase from the underwriter 2,500,000 shares (the “Repurchase”). The Repurchase will be completed outside IQVIA